NASDAQ:UTMD
Utah Medical Products Inc.
Utah Medical Products Inc.'s revenue fell 5.8% in fiscal 2025 to $38.5M while operating margin fell to 29.6%, its lowest in 10 years. Free cash flow was $14.3M, 37.2% of revenue, and the diluted share count fell 7.5%.Summary generated from Utah Medical Products Inc.'s SEC filings. Latest annual report filed Mar 27, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$38.5M
Revenue growth−5.8%
Revenue, 5-yr CAGR−1.8%
Gross margin57.1%
Operating margin29.6%
Net margin29.3%
ROIC26.8%
Return on equity9.5%
Debt / equity0.00
Free cash flow$14.3M
FCF margin37.2%
Share count change−7.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 49 | 52 | 50 | 41 | 39 |
| Operating income | 19 | 20 | 17 | 14 | 11 |
| Net income | 15 | 16 | 17 | 14 | 11 |
| Free cash flow | 21 | 20 | 22 | 15 | 14 |
Recent filings
- 8-KRegulation FD disclosure
Aug 31, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 12, 2026 - 8-KResults of operations and financial condition
Jul 23, 2026 - 4Insider transaction report
Jul 1, 2026 - 4Insider transaction report
May 29, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 12, 2026 - 8-KResults of a shareholder vote
May 4, 2026 - 8-KResults of operations and financial condition
Apr 23, 2026